Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March, 5, 1991.

Bibliographic Details
Corporate Authors:	United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1991.
Series:	U.S. Congressional Hearings.
Subjects:	Clozapine > Marketing. Antipsychotic drugs > United States > Marketing. Schizophrenia > United States > Chemotherapy > Safety measures. Electronic books.
Online Access:	Connect to the full text of this electronic book

Available Online